I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 121 filers reported holding I MAB in Q1 2022. The put-call ratio across all filers is 1.75 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $732,265 | +30538.7% | 554,746 | -19.7% | 0.00% | -100.0% |
| Q1 2023 | $2,390 | +49.5% | 690,767 | +80.5% | 0.00% | 0.0% |
| Q4 2022 | $1,599 | -99.1% | 382,642 | +770.3% | 0.00% | – |
| Q3 2022 | $176,000 | -49.6% | 43,967 | +42.3% | 0.00% | – |
| Q2 2022 | $349,000 | -88.1% | 30,887 | -83.0% | 0.00% | -100.0% |
| Q1 2022 | $2,945,000 | -9.9% | 181,353 | +162.9% | 0.00% | 0.0% |
| Q4 2021 | $3,269,000 | -23.0% | 68,979 | +17.9% | 0.00% | -33.3% |
| Q3 2021 | $4,243,000 | +95.4% | 58,529 | +126.3% | 0.00% | +200.0% |
| Q2 2021 | $2,171,000 | -86.4% | 25,860 | -92.2% | 0.00% | -90.9% |
| Q1 2021 | $15,990,000 | +1012.0% | 329,896 | +981.7% | 0.01% | +1000.0% |
| Q4 2020 | $1,438,000 | +598.1% | 30,499 | +597.0% | 0.00% | – |
| Q3 2020 | $206,000 | -8.0% | 4,376 | -74.5% | 0.00% | -100.0% |
| Q1 2020 | $224,000 | – | 17,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $293,220 | 0.32% |
| HHLR ADVISORS, LTD. | 6,909,220 | $9,120,170 | 0.20% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $409,859 | 0.14% |
| Maso Capital Partners Ltd | 100,000 | $132 | 0.07% |
| Diametric Capital, LP | 122,953 | $162,297 | 0.07% |
| Artal Group S.A. | 850,000 | $1,122 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 195,546 | $258 | 0.02% |
| Headlands Technologies LLC | 7,394 | $9,760 | 0.01% |
| Temasek Holdings (Private) Ltd | 566,650 | $747,978 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,471 | $52,102 | 0.00% |